Tumor structure and extracellular matrix as a possible barrier for therapeutic approaches using immune cells or adenoviruses in colorectal cancer

Histochemistry and Cell Biology

Volumn 115, Issue 1, 2001, Pages 67-72

  Kuppen, Peter J K ^a   Van der Eb, Marjolijn M ^a   Jonges, Liesbeth E ^a   Hagenaars, Martin ^a   Hokland, Marianne E ^b   Nannmark, Ulf ^c   Goldfarb, Ronald H ^d   Basse, Per H ^e   Fleuren, Gert Jan ^a   Hoeben, Rob C ^a   Van de Velde, Cornelis J H ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b AARHUS UNIVERSITY   (Denmark)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

^d UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

^e UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

Adenovirus; Colorectal cancer therapy; Extracellular matrix; Tumor immune response; Tumor structure

Indexed keywords

BETA GALACTOSIDASE; PROTEIN P53; SCLEROPROTEIN;

ADENOVIRUS; ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL; CANCER IMMUNOTHERAPY; COLORECTAL CANCER; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FEMALE; GENE TARGETING; GENE THERAPY; HUMAN; HUMAN TISSUE; IMMUNOCOMPETENT CELL; MAJOR CLINICAL STUDY; MALE; MORPHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPORTER GENE; STROMA CELL; TUMOR CELL;

ADENOVIRIDAE; ANIMALIA;

EID: 0035106337     PISSN: 09486143     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004180000224     Document Type: Article

References (25)

1. Matrix me-talloproteinases of human NK cells
2. Loss-of-function genetics in mammalian cells: The p53 tumor suppressor model
3. Monoclonal antibody to a triggering structure expressed on rat natural killer cells and adherent lymphokine-activated killer cells
4. Antibodies defining rat endothelial cells: RECA-1, a pan-endothelial cell-specific monoclonal antibody
5. Severe hepatic dysfunction after adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene and ganciclovir administration
6. Lym-phokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes
7. Characteristics of tumor infiltration by adoptively transferred and endogenous natural-killer cells in a syngeneic rat model: Implications for the mechanism behind anti-tumor responses
8. Regional administration of natural killer cells in a rat hepatic metastasis model results in better tumor infiltration and anti-tumor response than systemic administration
9. Infiltration of mononuclear inflammatory cells into primary colorectal carcinomas: An immunohistological analysis
10. A monoclonal antibody to a constant determinant of the rat T cell antigen receptor that induces T cell activation. Differential reactivity with subsets of immature and mature T lymphocytes
11. Secreted and membrane-associated matrix metalloproteinases of IL-2-activated NK cells and their inhibitors
12. Matrix metalloproteinases produced by rat IL-2-activated NK cells
13. Blood vessel invasion in metastatic nodes for development of liver metastases in colorectal cancer
14. Interferon treatment of a transplantable rat colon adenocarcinoma: Importance of tumor site
15. Role of stromal myofibro-blasts infiltrating colon cancer in tumor invasion
16. A phase I study of intralesional administration of an adenovirus vector expressing the HSV-1 thymidine kinase gene (AdV.RSV-TK) in combination with escalating doses of ganciclovir in patients with cutaneous meta-static malignant melanoma
17. Evidence that "myofibroblast-like" cells are the cellular source of capsular collagen in hepatocellular carcinoma
18. Distribution of a1(IV) and a3(IV) chains of type IV collagen in lung tumours
19. Lymphocyte development of adherence and motility in extracellular matrix during IL-2 stimulation
20. Recognition of tyrosinase by tumor-infiltrating lymphocytes from a patient responding to immunotherapy
21. Melanocytes in nevi and melanomas synthesize basement membrane and basement membrane-like material. An immunohistochemical and electron microscopic study including immunoelectron microscopy
22. Phase I clinical trial utilizing gene therapy for limb girdle muscular dystrophy: Alpha-, beta-, gamma-, or delta-sarcogly-can gene delivered with intramuscular instillations of adeno-associated vectors
23. Liver metastasis model of colon cancer in the rat: Immunohistochemical characterization
24. Phase I study of adenoviral delivery of the HSV-tk gene and ganciclovir administration in patients with current malignant brain tumors
25. Antigenic cancer cells grow progressively in immune hosts without evidence for T cell exhaustion or systemic anergy